Computational Approach to Decode the Mechanism of Curcuminoids Against Neuropathic Pain.
Chunxiao Xiang,Chunlan Chen,Xi Li,Yating Wu,Qing Xu,Lingmiao Wen,Wei Xiong,Yanjun Liu,Tinglan Zhang,Chongyang Dou,Xian Ding,Lin Hu,Fangfang Chen,Zhiyong Yan,Lingli Liang,Guihua Wei
DOI: https://doi.org/10.1016/j.compbiomed.2022.105739
IF: 7.7
2022-01-01
Computers in Biology and Medicine
Abstract:Background: Curcumin (CUR), demethoxycurcumin (DMC) and bisdemethoxycurcumin (BDMC) are the main components of turmeric that commonly used to treat neuropathic pain (NP). However, the mechanism of the therapy is not sufficiently clarified. Herein, network pharmacology, molecular docking and molecular dynamics (MD) approaches were used to investigate the mechanism of curcuminoids for NP treatment.Methods: Active targets of curcuminoids were obtained from the Swiss Target database, and NP-related targets were retrieved from GeneCards, OMIM, Drugbank and TTD databases. A protein-protein interaction (PPI) network was built to screen the core targets. Furthermore, DAVID was used for GO and KEGG pathway enrichment analyses. Interactions between potential targets and curcuminoids were assessed by molecular docking and the MD simulations were run for 100ns to validate the docking results on the top six complexes.Results: CUR, DMC, and BDMC had 100, 99 and 100 targets respectively. After overlapping with NP there were 33, 33 and 31 targets respectively. PPI network analysis of TOP 10 core targets, TNF, GSK3 beta were common targets of curcuminoids. Molecular docking and MD results indicated that curcuminoids bind strongly with the core targets. The GO and KEGG showed that curcuminoids regulated nitrogen metabolism, the serotonergic synapse and ErbB signaling pathway to alleviate NP. Furthermore, specific targets in these three compounds were also analysed at the same time. Conclusions: This study systematically explored and compared the anti-NP mechanism of curcuminoids, providing a novel perspective for their utilization.